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Abstract 
The Global Burden of Disease (GBD) study for the year 2016 reports a global disease burden of 0.32 DALY/person-year, given in disability-
specific DALYs per country for 188 countries. However, the human health impacts from all LCIA categories included in the ReCiPe global 
normalisation reference for the year 2012 together account for <0.02 DALY/person-year. The difference of 0.30 DALY/person-year represents 
mortality and morbidity that to a large extent are caused by human activities and for which we identify the corresponding elementary flows and 
unit processes that should be included in product life cycle inventories. In total, we attribute 37% of the GBD to one or more of 79 specific risk 
factors (e.g. air pollution or dietary risks). The remaining GBD, not attributable to specified risk factors, we then divide in two parts: The 
'Unavoidable GBD' (19%) and the residual (44%) that we find attributable to an 'insufficient health care system'. 
© 2017 The Authors. Published by Elsevier B.V. 
Peer-review under responsibility of the scientific committee of the 25th CIRP Life Cycle Engineering (LCE) Conference.  
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1. The Global Burden of Disease 
The Global Burden of Disease (GBD) study quantifies 
annually health loss for 188 countries across time, age, and 
sex, reported as Disability-Adjusted Life Years (DALY) per 
disability and country [1]. In a first consideration of how to 
include global human health impacts in life cycle assessments, 
we divide the reported DALY into three components: (i) one 
component representing the disease burden attributable to one 
or more of 79 risk factors currently considered in the GBD 
study, (ii) an 'unavoidable' component, which we define in 
relation to mortality and morbidity in the countries currently 
experiencing the lowest disease burden, and (iii) a residual 
component which we attribute to an 'insufficient health care 
system' as in principle avoidable by improving the availability, 
accessibility and quality of health care. 
The GBD study attributes about 45% of total DALY to 
specified risk factors, such as air pollution or dietary risks. Of 
these attributable DALY, 80% are mortality-related and 20% 
morbidity-related. For each of these risk factors, we compare 
these DALY to what is currently included in Life Cycle 
Impact Assessment (LCIA) and seek to identify the relevant 
human activities of the LCI (Life Cycle Inventory analysis) 
and their pressure indicators (cross-boundary LCI elementary 
flows) and to suggest additional improvements to the current 
LCIA impact pathway descriptions. For a few additional 
disabilities that are not currently attributed to risk factors in 
the GDB study, we perform a similar analysis.  
 
Nomenclature 
GBD         Global Burden of Disease  
DALY       Disability-Adjusted person-Life-Years (IHME) 
GDP     Gross Domestic Product 
IHME     Institute for Health Metrics and Evaluation 
LCIA         Life Cycle Impact Assessment 
LCI      Life Cycle Inventory analysis 
PAH      Polycyclic Aromatic Hydrocarbons 
PPP      Purchasing Power Parity 
© 201  The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of the scientifi c committee of the 25th CIRP Life Cycle Engineering (LCE) Conference 
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The remaining DALY, i.e. those not attributed to specific 
risk factors, we divided in two parts: an 'unavoidable burden' 
and a residual that we attribute to an 'insufficient health care 
system', which ultimately can be traced back to a pressure 
indicator 'underpayment of labour and taxes'. The 'unavoidable 
burden' is, with a few exceptions described below, defined by 
the 1st decile (i.e. lowest 10%) of country prevalence for each 
disability. The idea is that the “gold standard” for each 
disability is the best performing country in terms of 
prevalence, while removing the influence of extreme outliers 
that cannot be explained at this stage, by using the 1st decile 
rather than the minimum.  
Our analysis is performed on IHME-GBD DALY data for 
2016 (ghdx.healthdata.org), aggregated over both sexes and all 
age groups. We did not consider covariance between risk 
factors, which would require taking into account all relative 
risk functions in a more detailed analysis. 
2. Unavoidable burden of disease 
We use age-standardised DALY rates per 100,000 persons 
for each disability and each country to calculate the 1st decile 
of country prevalence for each disability across all countries. 
In general (see exceptions below), we used this 1st decile level 
as a cut-off for theoretically achievable prevalence in all 
countries, thereby ignoring potential inherent differences in 
minimum risk levels and within-country variation in 
prevalence. For each country, we then sum DALYs that fall 
below this 'achievable prevalence' as 'unavoidable burden of 
disease'. 
For some disabilities we used a different cut-off than the 1st 
decile of country prevalences. In line with GBD, we regard 
some disabilities as 100% attributable to specific risk factors, 
i.e. with a zero cut-off, while for some disabilities we go 
further than the GBD study. We use a zero cut-off for: 
• All disabilities related to drug and alcohol usage (GBD 
attributes only some), 
• Some potentially eradicable tropical diseases (lymphatic 
filariasis listed as potentially eradicable by the 
International Task Force for Disease Eradication, trachoma 
for which WHO has set an eradication target by 2020, and 
yellow fever for which an effective vaccine exists), 
• Nematode infections ascariasis and trichuriasis, which are 
fully preventable by sufficient sanitation, 
• Food-borne trematodiases, because it is fully preventable 
by freezing fish before raw consumption, 
• Mesothelioma, as this can be 100% attributed to avoidable 
asbestos contact, 
• Pneumoconiosis, as this can be 100% attributed to 
predominantly occupational dust exposure, 
• Hemoglobinopathies and hemolytic anemias, as these 
genetic diseases can be prevented in the long-term by 
carrier detection, 
• Nutritional deficiencies and neural tube defects as these 
can be attributed to undernutrition, 
• All road injuries, as the non-drug related residual can be 
attributed to motorized traffic, 
• All interpersonal and collective violence, as the non-drug 
related residual can be attributed to specific avoidable 
human behaviour. 
We regard some disabilities as being completely 
unavoidable, and thus use no cut-off, i.e. we attribute all 
related DALY as unavoidable for: 
• Chromosomal unbalanced rearrangements, congenital heart 
anomalies, endocrine, metabolic, blood, and immune 
disorders, as these are genetically caused, but not 
preventable as long as genetic markers are not identified, 
• The skin diseases psoriasis, acne vulgaris, and alopecia 
areata. 
For cataract, we use a cut-off of 9.9 DALY per 100,000 
persons corresponding to the lowest country prevalence (The 
Netherlands), as achievable by treatment. For chronic 
obstructive pulmonary disease (COPD), we set a cut-off of 40 
DALY per 100,000 persons, as an estimate of the prevalence 
of genetic causes. We use the median as cut-off for 'Other 
neglected tropical diseases', since the 1st decile is 
unrealistically low due to non-exposure of large parts of the 
populations. 
The resulting unavoidable GBD for 2016 is 460 million 
DALY or 19.2% of the total GBD or 0.11 DALY/person. The 
unavoidable DALY value per person is, as expected, rather 
invariant across countries (between 0.09 and 0.13 
DALY/person) but because of the large variation in total 
DALY/person in different countries, the unavoidable burden 
expressed as share of the total burden of disease varies from 
12% for Central African Republic to 63% for the Maldives. 
3. Poverty-related health impacts 
A large share of the avoidable GDB can be related to 
poverty. In this section, we identify and describe three impact 
pathways as entirely poverty-related: 'Insufficient health care 
system', 'Insufficient clean water supply and sanitation' and 
'Food insecurity'. We call the corresponding causal (LCI) 
pressure indicator for poverty 'Underpayment of labour and 
taxes', since poverty can be caused by either insufficient 
private income or insufficient funds for public services (see 
also Figure 2).  
3.1. Insufficient health care system 
We define the share of the burden of disease attributable to 
an 'Insufficient health care system' as the residual of the total 
2016 burden of disease when subtracting the unavoidable 
burden and the otherwise attributable burden (i.e. attributed to 
specified risk factors by the GBD study or as part of our 
analysis of the unavoidable burden). It should be noted that 
this implies a rather broad definition of “health care system” 
including also – and maybe in particular – preventive 
activities. Also, a part of the DALY attributed by the GBD 
study to specific risk factors we refer back to and include in 
'Insufficient health care' (see the sections “Undernutrition” 
and “Unsafe sexual practices” below). Nevertheless, we 
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expect that future identification of additional risk factors will 
mean that a part of the residual currently attributed to 
'Insufficient health care' will later be attributed to more 
specific human activities, for example a part of food-borne 
infections not yet attributed in the official GBD [2]. 
The resulting burden that we attribute to an 'Insufficient 
health care system' is 851 million DALY globally or 35.6% of 
the total GBD. This burden varies a lot between countries, 
especially for low-income countries; see Figure 1. 
Figure 1 shows that above a Purchasing-Power corrected 
GDP of 10,000 USD per person an increase in GDP does not 
necessarily lead to a more efficient health care system. It can 
be argued that this should lead us to place the cut-off for 
“unavoidable” disease burden higher than the 1st decile across 
countries. However, even the richest countries have a large 
income inequality that is known to reflect itself in health 
inequalities [3], which would be visible if we subdivided the 
country data into income groups. Under the current conditions 
of within-country income inequality, it would not be 
reasonable to expect the curve in Figure 1 to reach zero at the 
right end, since also the richer countries should be able to 
improve their health care systems for the poorer parts of their 
population. 
In Figure 1, a power fitted line has been added for 
illustration. It is not intended for extrapolation purposes, since 
actual values are available for each country of the world. The 
relatively large variation is expected, since GDP is not a direct 
driver for the efficiency of the health care system. We have 
also compared to other welfare-related indicators, such as 
GNI per person, health expenditure per person, and total 
DALY per person, all giving very similar fits. 
Figure 1. Insufficient health care in DALY/person-year versus country 
Purchasing-Power-corrected Gross Domestic Product (GDP) per person-year, 
calculated as residual by subtracting the “unavoidable burden” of disease and 
the otherwise attributable share from the total burden of disease. Each point 
represents one country. 
3.2. Insufficient clean water supply and sanitation 
A large part (94-96%) of the diarrheal diseases, typhoid 
fever, and paratyphoid fever, as well as 14% of lower 
respiratory infections, are attributed to the GBD risk factor 
'Unsafe water, sanitation, and handwashing'. We also include 
here the faeces-borne nematode infections ascariasis and 
trichuriasis. The GDB for this risk factor is 80 million DALY 
(3.4% of the GBD). 
Insufficient clean water supply and sanitation includes also 
insufficient wastewater treatment and use of untreated human 
excreta as fertiliser. 
3.3. Undernutrition 
We attribute all child and maternal malnutrition in the 
GDB study, as well as all neural tube defects, to 
'Undernutrition'. The avoidable GDB for undernutrition 
amounts to 109 million DALY (4.6% of overall GBD). The 
risk factor 'Suboptimal breastfeeding' of the GBD study can 
partly be related back to the workplace environment (based on 
the relatively scarce studies we have been able to find in this 
field [4,5], we estimate that 50% can be related to the early 
return to work after giving birth and 10% can be avoided by 
providing paid breaks for breastfeeding; in combination 55%) 
and partly to insufficient health care advice, the latter (i.e. the 
remaining 45%) thus included in the above burden attributed 
to an 'Insufficient health care system'. With the current data 
availability, we cannot distinguish the remaining causes of 
undernutrition, but relate all to poverty-related 'Food 
insecurity', except for a small part (7.5%) that can be related 
to 'Household gender discrimination', for which we use 
'Intimate partner violence' as the only available proximate risk 
factor (see below section “Violence”). Beyond the direct 
health effects covered by these impact pathway descriptions, 
there is also influence on intelligence (reduced cognitive 
skills), which is not quantified here. 
4. Disabilities attributable to specific activities 
Besides the poverty-related disease burden described in the 
previous section, we detail in the present section how we 
relate the remaining attributable GBD (attributed to specified 
risk factors by the GBD study or as part of our above analysis 
of the unavoidable burden) to specific human activities and 
their pressure indicators. 
In the following descriptions of the attributable disabilities, 
some will already be covered by existing LCI pressure 
indicators, while many are not. We further evaluate the extent 
to which these burdens are adequately covered in existing LCI 
databases and LCIA methods. For burdens currently not 
considered in LCA, new LCIA data and impact categories are 
needed. 
The structure of this section follows the large groups of 
risk factors from the GBD study, in order of decreasing global 
importance (decreasing numbers of DALY). 
4.1. Dietary risks 
The GBD study attributes 229 million DALY (9.6% of 
total GBD) to dietary risks from an unbalanced diet, more 
specifically a diet low in fruits, vegetables, whole grains, nuts 
and seeds, milk, fibre, calcium, polyunsaturated fatty acids, 
and omega-3 fatty acids or precursors, high in red meat, 
processed meat, sugar-sweetened beverages, trans fatty acids, 
and sodium. These health effects can be related to the 
marginal influence of the individual food items on the diet, as 
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a result of the dietary choices made in the food preparation 
and consumption stages of the food life cycles. 
4.2. Particulate matter exposure 
Particulate matter exposure includes exposure to ambient 
air emissions (106 million DALY), occupational exposure 
(9.4 million DALY), and household exposure from 
combustion (77 million DALY), in total 192 million DALY 
(8% of total GBD). The resulting disease burden is attributed 
to pneumoconiosis (occupational), lower respiratory 
infections, stroke, ischemic heart disease, chronic obstructive 
pulmonary disease and lung cancer; for household exposure 
also cataract. The GBD study rests on a large amount of 
exposure data. A relation to sources is made using PM 
composition. Health impacts from particulate matter exposure 
are already relatively well covered in LCI databases. 
4.3. Smoking 
The GBD study attributes 177 million DALY (7.4% of 
total GBD) to smoking, mainly of tobacco. 13.4% of this is 
due to second-hand smoke, mainly in households. The GBD 
study uses a dichotomous measure of exposure defined as 
current daily use of smoked tobacco (and prevalence of 
second-hand smoke in household and in occupational 
settings). In an LCI context, it would potentially be more 
logical to relate this disease burden to the quantity of tobacco 
consumed. 
4.4. Misuse of drugs (including alcohol) 
The GBD study attributes 131 million DALY (5.5% of 
total GBD) to drug use, out of which 99 million DALY (4.2% 
of total GBD) are from alcohol misuse and the majority of the 
rest is from misuse of opioids. 30 million DALY are caused 
by injuries related to misuse of alcohol (included in the 
aforementioned value). The attribution of misuse to human 
activities may be controversial, where some may regard the 
substance itself – and thus its production – as decisive, while 
others argue that the majority of misuse is related to social 
exclusion and can therefore be traced back to social LCI 
pressure indicators, such as 'Unemployment' and 
'Discrimination'. 
4.5. Transport injuries 
Transport injuries amount to 84 million DALY (3.5% of 
total GBD), of which the GBD study attributes 36% to alcohol 
use and 3% to tobacco use, while 45% are in GBD attributed 
to occupational transport injuries. In some LCA studies, data 
on fatal and non-fatal injuries per million vehicle-km have 
already been included. It should hence be generally possible 
to include transport-related injuries in LCI and to characterize 
their related health impacts, while accounting for variations 
depending on e.g. driving habits, traffic enforcement, and 
road conditions. 
4.6. Unsafe sexual practices 
A burden of 55 million DALY (2.3% of total GBD) of 
sexually transmitted diseases, including cervical cancer and 
HIV/AIDS, can be attributed to unsafe sexual practices 
(household activities typically unrelated to any product life 
cycles), except for 5% attributed to violence. In some 
countries, a part of the unsafe sexual practices may be traced 
back to a lack of access to condoms or police harassment of 
sex workers, and thus can be included in our 'Insufficient 
health care' category. Statistics on the prevalence of condom 
accessibility and usage by country and for specific population 
groups is very patchy. The only systematic, annual data are 
prevalence data for 'Unmet need for family planning' and 
'Demand for family planning satisfied with modern methods' 
among 15-49 year old women living with a partner [16]. It is a 
reasonable assumption that sufficient access to condoms in 
general is at least not higher than the unsatisfied demand for 
family planning with modern methods (of which condoms is 
one), and we therefore use these data as a (best-case) proxy 
for insufficient access to condoms as risk factor, and thus for 
the share of the unsafe sexual practices included under 
'Insufficient health care' per country. 
4.7. Lack of physical activity 
The GBD study attributes 24 million DALY (1% of total 
GBD) to 'low physical activity', divided among ischemic heart 
disease, diabetes, stroke, colon cancer, and breast cancer. This 
corresponds to a burden for activity levels below the WHO 
minimum recommendation of 600 metabolic equivalent-
minutes (MET-minutes) per week. Relative changes in risk 
per MET-minute/week are provided by [11], which could be 
converted into a DALY value per MET-minute/hour. A 
related LCI pressure indicator could potentially be defined for 
every hour of activity deviating positively or negatively from 
the average MET-level. MET-levels for many activities are 
included in [12]. Data on sedentary work per industry, 
occupation, and skill level are available from Australia [13]. 
4.8. Ergonomics 
Ergonomically inappropriate equipment can lead to 
physical strain and discomfort. While the potential damages 
may obviously be of very diverse nature, and also have 
impacts on productivity at below-clinical levels, the 
quantification in the GBD study is limited to 20 million 
DALY (0.8% of total GDB), of which 71% of all cases are 
attributed to low back pain. The GBD values can be related to 
the industries in LCI based on occupational health statistics. 
4.9. Non-transport related occupational injuries and noise 
Occupational injuries amount in the GBD study to 4% of 
all injuries or 11 million DALY (0.5% of total GBD). Hearing 
loss from occupational noise exposure amounts to 7.1 million 
DALY (0.3% of total GBD). The GBD study provides data on 
occupational exposure per economic activity that can be used 
to relate the GBD values to the industries in LCI. More 
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detailed statistics for some countries may be used for 
extrapolation to countries with no or insufficiently detailed 
statistics, while considering differences in technologies and 
safety standards enforcement. 
4.10.  Emission-related cancers 
Of 213 million DALY (9% of GBD) for cancers 
(malignant neoplasms), 40% or 85 million DALY are 
currently attributed to specific risk factors by the GBD study, 
out of which only a smaller part (17 million DALY or 8% of 
all cancers) is emissions-related (attributed to particulates, 
radon and specific occupational exposures). Clearly, there are 
more potentially carcinogenic substances than the ones 
accounted for in the GDB study, but a few substances in 
current LCI databases typically dominate LCA results 
(notably arsenic, cadmium, dioxins, formaldehyde, lead, 
mercury, nickel and PAHs emitted to air, and cadmium, lead 
and nickel emitted to soil) summing to a potential burden of 
less than 1 million DALY globally when using USEtox 
normalisation reference and health impact factors. This can be 
compared to the 7.2 million DALY attributed to occupational 
risk factors by the GBD study. For chemical substances, 
exposure is dominated by worker and consumer exposure to 
articles, sprays, foods, etc. [6], not currently included in 
LCAs, except for some indoor air emissions. 
4.11. Lead exposure 
The GBD study attributes 14 million DALY to lead 
exposure (0.6% of GBD), distributed on cardiovascular 
diseases (74%), idiopathic developmental intellectual 
disability (21%), and chronic kidney disease (5%). The GBD 
estimate covers both outdoor and indoor exposure. According 
to [10], for sources and speciation of Pb emissions from 
intentional use from 1930 onwards to 3.6E+6 kg total 
emissions in 2010, intentional use accounts for more than 
50% of total emissions. The EXIOBASE 2011 LCI database 
appears to overestimate emissions from steel manufacture and 
shows a total of lead emissions to air of 150E+6 kg, i.e. 50 
times the total loss of lead reported by [10], but with the 
USEtox characterisation factors this still only amounts to 6.6 
million DALY. The most important human exposure pathway 
is ingestion of contaminated foods. 
4.12. Exposure to other toxic emissions 
The USEtox global normalisation reference updated with 
the EXIOBASE 2011 global emissions and combined with the 
USEtox characterisation factors give a total potential human 
health impact related to exposure to non-carcinogenic human 
toxic chemical emissions of 4 million DALY (0.2% of GBD). 
While this is likely to be only part of the full picture, it does 
not immediately appear as an area of concern. The main need 
for improving LCA, however, is the inclusion of currently 
missing but potentially dominating exposure environments for 
toxic chemicals, namely worker and consumer exposure. 
4.13. Violence 
The GBD study attributes 8.2 million DALY (0.34% of 
total GBD) to intimate partner violence and childhood sexual 
abuse. In an LCI context, this could be included as separate 
activities, not related to any product life cycles. Besides the 
direct effects of interpersonal violence, intimate partner 
violence is also the only available proximate risk factor for 
'Household gender discrimination', to which we attribute 7.5% 
of 'Undernutrition' not otherwise attributed, based on [14] 
finding an odds ratio of 1.48 (95% confidence interval 1.23-
1.79) for women with lifetime experience of physical intimate 
partner violence to have a stunted child (under 5 years). The 
total number of such women in poor households with lifetime 
exposure to violence is 620 million or 17% of all women 
(calculated from [15]). 
4.14. Photochemical ozone exposure 
The GBD study attributes 3.8 million DALY (0.16% of 
GBD) from chronic obstructive pulmonary disease to 
emissions of chemicals with photochemical ozone formation 
potential. The ReCiPe, ILCD and ImpactWorld+ LCIA 
methods all use the atmospheric chemistry model LOTOS-
EUROS [7], which is based on the same method as the model 
used by the GDB study, but give only approximately 60% of 
the GBD results. 
4.15. Asthmagens exposure 
For occupational exposure to asthmagens, the GBD study 
attributes 2.3 million DALY, which is only 10% of all asthma 
cases, since causal relationships between individual risk 
factors and asthma are still poorly understood. Asthma 
accounts for 1% of the global disease burden. The AOEC 
exposure code lookup tool (http://www.aoecdata.org/ 
ExpCodeLookup.aspx) provides a list of 518 asthmagens, but 
specific emission and exposure data for these are not readily 
available to build a related impact pathway. 
4.16. Food-borne trematodiases 
All cases of food-borne trematodiases (1.8 million DALY; 
0.07% of total GBD) could be related to a new LCI pressure 
indicator for 'Insufficient freezing of fish before raw 
consumption'. 
4.17. Ionising radiation 
Residential radon exposure is the largest source of ionising 
radiation exposure for humans, and the only one included in 
the GBD risk attributions with 1.3 million DALY (0.05% of 
GBD) from tracheal, bronchus, and lung cancer. UNSCEAR 
estimate 42,000 Man-Sv from occupational expose (specified 
by industry), i.e. 49,000 DALY or 3.5% of the GBD radon 
value, mainly from coal mining (16,000 Man-Sv) and other 
mining (14,000 Man-Sv); the next important source is medical 
use [8]. Current LCI databases appear to include only 
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industrial emissions and are dominated by C-14 from nuclear 
power plants [9], and hence should be extended. 
5. Conclusion 
Figure 2 provides an overview of the suggested impact 
pathways linking an avoidable 81% of the global disease 
burden either to the pressure indicator of underpayment of 
labour and taxes or to specific human activities (non-income-
related inventory items). 
Underpayment of labour and taxes can be measured 
relative to a reference level sufficient to eliminate the residual 
avoidable GDB, as suggested in [17]. The relationship 
between this pressure indicator and disposable private and 
public income depends also on income redistribution, which 
has not been included in our current model. 
Insufficient health care can be caused both directly by 
insufficient private income and indirectly by insufficient 













Figure 2. Impact pathways from human activities to the avoidable GDB 2016. 
6. Outlook 
Our analysis is a preliminary proof-of-concept for linking 
the Global Burden of Disease to human activities and thus to 
product life cycles. The analysis can be improved as follows: 
• In general, uncertainty should be added to all health data 
presented above, using the confidence intervals from all 
relative risk models used to calculate the GBD. 
• For diseases that have several causes, the total DALYs 
reported above may be overestimated when adding the 
DALYs from each separate cause. It would be possible to 
avoid such overestimations by applying a more detailed 
analysis using the same models of co-variance as used for 
the GBD study. Such detailed analyses, however, were 
beyond our resources for this initial analysis. 
• Additional risk factors should be identified and 
incorporated in our analysis as quantified, e.g., for food-
borne infections [2], to reduce the part of GBD that is 
currently attributed to the more generic 'insufficient health 
care'. 
• DALYs finally attributable to insufficient health care 
should be systematically linked either to the financing and 
efficiency of public health services or to personal income 
equality, taking into account also the effect of income 
redistribution. 
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